| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
|
J Clin Oncol
|
2008
|
7.01
|
|
2
|
Pulmonary complications after esophagectomy.
|
Ann Thorac Surg
|
2002
|
3.35
|
|
3
|
Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
|
Cancer
|
2002
|
2.82
|
|
4
|
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery.
|
Chest
|
2002
|
2.79
|
|
5
|
Optimum lymphadenectomy for esophageal cancer.
|
Ann Surg
|
2010
|
2.01
|
|
6
|
An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy.
|
Ann Thorac Surg
|
2002
|
1.80
|
|
7
|
Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration.
|
Chest
|
2005
|
1.62
|
|
8
|
Accuracy of EUS in staging of T4 lung cancer.
|
Gastrointest Endosc
|
2004
|
1.60
|
|
9
|
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer.
|
Am J Respir Crit Care Med
|
2003
|
1.42
|
|
10
|
Sustained supervised practice on a coronary anastomosis simulator increases medical student interest in surgery, unsupervised practice does not.
|
Ann Thorac Surg
|
2013
|
1.39
|
|
11
|
Epidemiology of esophageal cancer.
|
Surg Clin North Am
|
2012
|
1.29
|
|
12
|
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.
|
J Thorac Cardiovasc Surg
|
2007
|
1.11
|
|
13
|
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.
|
Ann Thorac Surg
|
2008
|
1.10
|
|
14
|
Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers.
|
J Thorac Cardiovasc Surg
|
2010
|
1.00
|
|
15
|
Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography.
|
Ann Thorac Surg
|
2004
|
0.99
|
|
16
|
Lung and bronchus cancer disparities in South Carolina: epidemiology and strategies for prevention.
|
J S C Med Assoc
|
2006
|
0.96
|
|
17
|
Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer.
|
Gastrointest Endosc
|
2002
|
0.96
|
|
18
|
Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung.
|
J Thorac Cardiovasc Surg
|
2010
|
0.95
|
|
19
|
Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
|
Ann Thorac Surg
|
2008
|
0.92
|
|
20
|
Esophageal cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
|
J S C Med Assoc
|
2006
|
0.91
|
|
21
|
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR.
|
Clin Cancer Res
|
2005
|
0.90
|
|
22
|
Sternoclavicular joint infection necessitating through skin and lung parenchyma.
|
Ann Thorac Surg
|
2010
|
0.88
|
|
23
|
Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
|
Ann Thorac Surg
|
2012
|
0.86
|
|
24
|
Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents.
|
J Thorac Cardiovasc Surg
|
2009
|
0.85
|
|
25
|
Locally advanced esophageal cancer.
|
Curr Treat Options Oncol
|
2002
|
0.84
|
|
26
|
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.
|
J Nucl Med
|
2006
|
0.83
|
|
27
|
Invasive thymoma with endobronchial metastasis.
|
Ann Thorac Surg
|
2010
|
0.81
|
|
28
|
FDG-PET uptake in occult acute pelvic fracture.
|
Skeletal Radiol
|
2003
|
0.81
|
|
29
|
Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer.
|
Am J Clin Oncol
|
2010
|
0.80
|
|
30
|
Adenocarcinoma of the esophagus with signet ring cell features portends a poor prognosis.
|
Ann Thorac Surg
|
2013
|
0.79
|
|
31
|
Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
|
Jpn J Clin Oncol
|
2010
|
0.79
|
|
32
|
Where the twains should meet.
|
Clin Gastroenterol Hepatol
|
2008
|
0.75
|
|
33
|
One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer.
|
Chest
|
2003
|
0.75
|
|
34
|
Contemporary management of esophageal malignancy.
|
Surg Clin North Am
|
2012
|
0.75
|
|
35
|
Patient versus customer, technology versus touch: where has humanism gone?
|
Ann Thorac Surg
|
2008
|
0.75
|
|
36
|
Factors affecting interest in cardiothoracic surgery: survey of North American general surgery residents.
|
Ann Thorac Surg
|
2009
|
0.75
|
|
37
|
Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer.
|
Am J Clin Oncol
|
2003
|
0.75
|
|
38
|
Diffuse esophageal polyposis: an uncommon occurrence.
|
Ann Thorac Surg
|
2009
|
0.75
|